Annals of the New York Academy of Sciences

Cover image for Vol. 1180 Biomarkers in Brain Disease

October 2009

Volume 1180 Biomarkers in Brain Disease

Pages vii–vii, 1–124

  1. Preface

    1. Top of page
    2. Preface
    3. Original Articles
    1. Preface (page vii)

      Simon Lovestone

      Version of Record online: 3 NOV 2009 | DOI: 10.1111/j.1749-6632.2009.05107.x

  2. Original Articles

    1. Top of page
    2. Preface
    3. Original Articles
    1. You have free access to this content
      The Uses of Biomarkers in Drug Development (pages 1–10)

      Orest Hurko

      Version of Record online: 3 NOV 2009 | DOI: 10.1111/j.1749-6632.2009.04946.x

    2. Biomarkers, Dementia, and Public Health (pages 11–19)

      C. F. Wright, A. Hall, F. E. Matthews and C. Brayne

      Version of Record online: 3 NOV 2009 | DOI: 10.1111/j.1749-6632.2009.04942.x

    3. Imaging Biomarkers in Alzheimer's Disease (pages 20–27)

      Natalie S. Ryan and Nick C. Fox

      Version of Record online: 3 NOV 2009 | DOI: 10.1111/j.1749-6632.2009.05062.x

    4. CSF Biomarkers : Pinpointing Alzheimer Pathogenesis (pages 28–35)

      Niklas Mattsson, Kaj Blennow and Henrik Zetterberg

      Version of Record online: 3 NOV 2009 | DOI: 10.1111/j.1749-6632.2009.04944.x

    5. AddNeuroMed—The European Collaboration for the Discovery of Novel Biomarkers for Alzheimer's Disease (pages 36–46)

      Simon Lovestone, Paul Francis, Iwona Kloszewska, Patrizia Mecocci, Andrew Simmons, Hilkka Soininen, Christian Spenger, Magda Tsolaki, Bruno Vellas, Lars-Olof Wahlund, Malcolm Ward and on behalf of the AddNeuroMed Consortium

      Version of Record online: 3 NOV 2009 | DOI: 10.1111/j.1749-6632.2009.05064.x

    6. MRI Measures of Alzheimer's Disease and the AddNeuroMed Study (pages 47–55)

      Andrew Simmons, Eric Westman, Sebastian Muehlboeck, Patrizia Mecocci, Bruno Vellas, Magda Tsolaki, Iwona Kłoszewska, Lars-Olof Wahlund, Hilkka Soininen, Simon Lovestone, Alan Evans, Christian Spenger and for the AddNeuroMed Consortium

      Version of Record online: 3 NOV 2009 | DOI: 10.1111/j.1749-6632.2009.05063.x

    7. Identifying Early Markers of Alzheimer's Disease using Quantitative Multiplex Proteomic Immunoassay Panels (pages 56–67)

      Holly D. Soares, Yu Chen, Marwin Sabbagh, Alex Rohrer, Elisabeth Schrijvers and Monique Breteler

      Version of Record online: 3 NOV 2009 | DOI: 10.1111/j.1749-6632.2009.05066.x

      Corrected by:

      Corrigendum for Ann. N. Y. Acad. Sci. 1180: 56–67

      Vol. 1188, Issue 1, 231, Version of Record online: 23 FEB 2010

    8. Proteomics for Brain Disorders—The Promise for Biomarkers (pages 68–74)

      Malcolm Ward, Andreas Güntert, James Campbell and Ian Pike

      Version of Record online: 3 NOV 2009 | DOI: 10.1111/j.1749-6632.2009.05018.x

    9. Use of Genetic Variation as Biomarkers for Alzheimer's Disease (pages 75–96)

      Christiane Reitz and Richard Mayeux

      Version of Record online: 3 NOV 2009 | DOI: 10.1111/j.1749-6632.2009.04945.x

    10. Biomarkers in Huntington's and Parkinson's Disease (pages 97–110)

      Gráinne C. O’Keeffe, Andrew W. Michell and Roger A. Barker

      Version of Record online: 3 NOV 2009 | DOI: 10.1111/j.1749-6632.2009.04943.x

    11. Biomarkers in Oncology : Trials and Tribulations (pages 111–118)

      Sheila E. Taube

      Version of Record online: 3 NOV 2009 | DOI: 10.1111/j.1749-6632.2009.05019.x

    12. Biomarkers in Alzheimer's Disease : Not Yet Surrogate Endpoints (pages 119–124)

      N Coley, S Andrieu, J Delrieu, T. Voisin and B. Vellas

      Version of Record online: 3 NOV 2009 | DOI: 10.1111/j.1749-6632.2009.04947.x

SEARCH

SEARCH BY CITATION